Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Updated to revision v3.0.2 and removed the v3.0.1 tag along with the 'Back to Top' link. This is a minor maintenance update with no substantive changes to core content, pricing, or time slot information.
    Difference
    0.2%
    Check dated 2025-09-15T00:58:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T21:05:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include specific details about Hodgkin lymphoma treatment efficacy, including a new facility name and location, while removing several previous location-related terms and some medical terminology.
    Difference
    3%
    Check dated 2025-08-30T15:32:57.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has removed a significant publication reference regarding the five-year follow-up of pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
    Difference
    0.3%
    Check dated 2025-08-23T14:11:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-16T12:09:24.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T07:45:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.